In today's medical environment, personalised medicine is a significant movement. It tries to shift the focus away from the old practise of prescribing standard doses of standard medications to every patient for a condition and toward targeting the specific drug and dose required based on the patient's physiology. Nanotechnology and personalised medicine are two of the newest areas of biomedical research, as well as two of the most promising technologies for enhancing health care and outcomes. In addition, they are fast convergent in a variety of current and future therapeutic applications. Nanotechnology has a number of benefits for personalised medicine applications, including a size that matches the scale of personalised medicine's molecular substrates, increased sensitivity in detecting and binding with target molecules, and flexibility in the design and features of diagnostics and therapeutics at the nano scale.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States